Timing Is everything: Brca2 and p53 mutations in pancreatic cancer

Gastroenterology

Volumn 140, Issue 4, 2011, Pages 1143-1146

  Morton, Jennifer P ^a   Steele, Colin W ^a   Sansom, Owen J ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; DNA; GEMCITABINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DNA REPAIR; DNA STRAND BREAKAGE; DRUG TARGETING; FAMILIAL CANCER; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW;

EID: 79953213660     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.02.026     Document Type: Editorial

References (22)

1. The Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1999 1310 1316
2. K.M. Murphy, K.A. Brune, and C. Griffin Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% Cancer Res 62 2002 3789 3793 (Pubitemid 34728862)
3. C. Shi, R.H. Hruban, and A.P. Klein Familial pancreatic cancer Arch Pathol Lab Med 133 2009 365 374
4. S.A. Hahn, B. Greenhalf, and I. Ellis BRCA2 germline mutations in familial pancreatic carcinoma J Natl Cancer Inst 95 2003 214 221 (Pubitemid 36240634)
5. R.H. Hruban, R.E. Wilentz, and S.E. Kern Genetic progression in the pancreatic ducts Am J Pathol 156 2000 1821 1825 (Pubitemid 30641750)
6. P.C. Fong, D.S. Boss, and T.A. Yap Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N Engl J Med 361 2009 123 134
7. P.C. Fong, T.A. Yap, and D.S. Boss Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval J Clin Oncol 28 2010 2512 2519
8. Y. Drew, E.A. Mulligan, and W.T. Vong Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2 J Natl Cancer Inst 2010 Dec 23 [Epub ahead of print]
9. H.E. Bryant, N. Schultz, and H.D. Thomas Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913 917 (Pubitemid 40559005)
10. M. Rowley, A. Ohashi, and G. Mondal Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice Gastroenterology 140 2011 1303 1313
11. G. Schneider, J.T. Siveke, and F. Eckel Pancreatic cancer: basic and clinical aspects Gastroenterology 128 2005 1606 1625 (Pubitemid 40692555)
12. C. Almoguera, D. Shibata, and K. Forrester Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
13. J.P. Morton, N.B. Jamieson, and S.A. Karim LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest Gastroenterology 139 2010 586 597
14. S. Grover, and S. Syngal Hereditary pancreatic cancer Gastroenterology 139 2010 1076 1080
15. P.W. Heiser, D.A. Cano, and L. Landsman Stabilization of beta-catenin induces pancreas tumor formation Gastroenterology 135 2008 1288 1300
16. T. Crook, L.A. Brooks, and S. Crossland p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours Oncogene 17 1998 1681 1689 (Pubitemid 28482645)
17. J. Jonkers, R. Meuwissen, and H. van der Gulden Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer Nat Genet 29 2001 418 425 (Pubitemid 34326692)
18. F. Skoulidis, L.D. Cassidy, and V. Pisupati Germline Brca2 heterozygosity promotes Kras(G12D)-driven carcinogenesis in a murine model of familial pancreatic cancer Cancer Cell 18 2010 499 509
19. J. O'Shaughnessy, C. Osborne, and J.E. Pippen Iniparib plus chemotherapy in metastatic triple-negative breast cancer N Engl J Med 364 2011 205 214
20. K.P. Olive, M.A. Jacobetz, and C.J. Davidson Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
21. J.P. Morton, S.A. Karim, and K. Graham Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma Gastroenterology 139 2010 292 303
22. G. Finak, N. Bertos, and F. Pepin Stromal gene expression predicts clinical outcome in breast cancer Nat Med 14 2008 518 527 (Pubitemid 351655218)